Published in PLoS Pathog on September 07, 2017
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol (1991) 5.71
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60
Role of superantigens in human disease. J Infect Dis (1993) 2.62
The bacterial superantigen and superantigen-like proteins. Immunol Rev (2008) 2.44
Bacterial superantigens. Clin Exp Immunol (2003) 2.42
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem (1987) 2.27
Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. MBio (2012) 2.26
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science (1994) 2.24
Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol (2008) 1.97
Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev (1995) 1.95
SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J Infect Dis (2010) 1.76
The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis (2009) 1.74
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol (2005) 1.67
The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals. J Bacteriol (2008) 1.58
Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost (2009) 1.56
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood (2007) 1.47
Regulatory organization of the staphylococcal sae locus. Microbiology (2008) 1.47
Superantigens - powerful modifiers of the immune system. Mol Med Today (2000) 1.43
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog (2011) 1.37
In the Staphylococcus aureus two-component system sae, the response regulator SaeR binds to a direct repeat sequence and DNA binding requires phosphorylation by the sensor kinase SaeS. J Bacteriol (2010) 1.35
TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30
The Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J Biol Chem (2002) 1.28
Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood (2008) 1.16
Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol (2012) 1.15
Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood (2002) 1.13
Interplay between superantigens and immunoreceptors. Scand J Immunol (2004) 1.11
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol (2007) 1.07
The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. J Mol Biol (2005) 1.07
Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins. J Bacteriol (2012) 1.06
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol (2011) 1.06
Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J (2007) 1.03
Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol (2007) 1.02
Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol (2011) 0.99
Streptococcal superantigens: categorization and clinical associations. Trends Mol Med (2013) 0.97
Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med (Berl) (2012) 0.95
Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner. PLoS Pathog (2014) 0.95
Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule. J Biol Chem (2006) 0.95
Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils. Infect Immun (2010) 0.93
Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol (2009) 0.92
Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J Immunol (2010) 0.92
Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol (2010) 0.91
Characterization of a mouse-adapted Staphylococcus aureus strain. PLoS One (2013) 0.91
Identification and Characterization of a Novel Staphylococcal Emetic Toxin. Appl Environ Microbiol (2015) 0.89
Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun (2012) 0.89
Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses. Biochem Soc Trans (2011) 0.89
Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun (2014) 0.87
Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus. FEMS Microbiol Rev (2015) 0.86
CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia. J Infect Dis (2014) 0.83
Staphylococcus aureus vaccines: Deviating from the carol. J Exp Med (2016) 0.82
A conserved mechanism of T lymphocyte stimulation by microbial exotoxins. Microb Pathog (1989) 0.81
Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display. Cell Microbiol (2014) 0.81
GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS One (2011) 0.80
Structural and functional properties of staphylococcal superantigen-like protein 4. Infect Immun (2012) 0.80
Full functional activity of SSL7 requires binding of both complement C5 and IgA. Immunol Cell Biol (2013) 0.79
The expression of a putative exotoxin and an ABC transporter during bovine intramammary infection contributes to the virulence of Staphylococcus aureus. Vet Microbiol (2012) 0.76
Rapid Amplification of cDNA Ends for RNA Transcript Sequencing in Staphylococcus. Methods Mol Biol (2016) 0.76
The changing landscape of antimicrobial resistance in New Zealand. N Z Med J (2014) 0.76
Staphylococcus aureus coagulase R domain, a new evasion mechanism and vaccine target. J Exp Med (2016) 0.75
A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia. Med Microbiol Immunol (2017) 0.75